These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 30467731)

  • 21. Treatment with eldecalcitol positively affects mineralization, microdamage, and collagen crosslinks in primate bone.
    Saito M; Grynpas MD; Burr DB; Allen MR; Smith SY; Doyle N; Amizuka N; Hasegawa T; Kida Y; Marumo K; Saito H
    Bone; 2015 Apr; 73():8-15. PubMed ID: 25482210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential maintenance of cortical and cancellous bone strength following discontinuation of bone-active agents.
    Shahnazari M; Yao W; Wang B; Panganiban B; Ritchie RO; Hagar Y; Lane NE
    J Bone Miner Res; 2011 Mar; 26(3):569-81. PubMed ID: 20839286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Six Weeks of Daily Abaloparatide Treatment Increased Vertebral and Femoral Bone Mineral Density, Microarchitecture and Strength in Ovariectomized Osteopenic Rats.
    Bahar H; Gallacher K; Downall J; Nelson CA; Shomali M; Hattersley G
    Calcif Tissue Int; 2016 Nov; 99(5):489-499. PubMed ID: 27395059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The therapeutic effect to eldecalcitol + bisphosphonate is superior to bisphosphonate alone in the treatment of osteoporosis: a meta-analysis.
    Zheng Z; Luo J
    J Orthop Surg Res; 2020 Sep; 15(1):390. PubMed ID: 32907639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined treatment with a beta-blocker and intermittent PTH improves bone mass and microarchitecture in ovariectomized mice.
    Pierroz DD; Bouxsein ML; Rizzoli R; Ferrari SL
    Bone; 2006 Aug; 39(2):260-7. PubMed ID: 16531131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Maintenance of increased bone mass after recombinant human parathyroid hormone (1-84) with sequential zoledronate treatment in ovariectomized rats.
    Rhee Y; Won YY; Baek MH; Lim SK
    J Bone Miner Res; 2004 Jun; 19(6):931-7. PubMed ID: 15125792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term therapy of ovariectomy-induced osteopenia with parathyroid hormone analog SDZ PTS 893 and bone maintenance in retired breeder rats.
    Thomsen JS; Mosekilde LI; Gasser JA
    Bone; 1999 Nov; 25(5):561-9. PubMed ID: 10574576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intermittent administration of human parathyroid hormone (1-34) increases fixation of strontium-doped hydroxyapatite coating titanium implants via electrochemical deposition in ovariectomized rat femur.
    Tao ZS; Zhou WS; Qiang Z; Tu KK; Huang ZL; Xu HM; Sun T; Lv YX; Cui W; Yang L
    J Biomater Appl; 2016 Feb; 30(7):952-60. PubMed ID: 26482573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of combined treatment with alendronate (ALN) and eldecalcitol, a new active vitamin D analog, compared to that of concomitant ALN, vitamin D plus calcium treatment in Japanese patients with primary osteoporosis.
    Sakai A; Ito M; Tomomitsu T; Tsurukami H; Ikeda S; Fukuda F; Mizunuma H; Inoue T; Saito H; Nakamura T;
    Osteoporos Int; 2015 Mar; 26(3):1193-202. PubMed ID: 25592133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Six-month daily administration of parathyroid hormone and parathyroid hormone-related protein peptides to adult ovariectomized rats markedly enhances bone mass and biomechanical properties: a comparison of human parathyroid hormone 1-34, parathyroid hormone-related protein 1-36, and SDZ-parathyroid hormone 893.
    Stewart AF; Cain RL; Burr DB; Jacob D; Turner CH; Hock JM
    J Bone Miner Res; 2000 Aug; 15(8):1517-25. PubMed ID: 10934650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequential treatment with basic fibroblast growth factor and PTH is more efficacious than treatment with PTH alone for increasing vertebral bone mass and strength in osteopenic ovariectomized rats.
    Iwaniec UT; Mosekilde L; Mitova-Caneva NG; Thomsen JS; Wronski TJ
    Endocrinology; 2002 Jul; 143(7):2515-26. PubMed ID: 12072383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eldecalcitol and calcitriol stimulates 'bone minimodeling,' focal bone formation without prior bone resorption, in rat trabecular bone.
    Saito H; Takeda S; Amizuka N
    J Steroid Biochem Mol Biol; 2013 Jul; 136():178-82. PubMed ID: 23069645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of different dosages of parathyroid hormone-related protein 1-34 on the bone metabolism of the ovariectomized rat model of osteoporosis.
    Xu J; Rong H; Ji H; Wang D; Wang J; Zhang W; Zhang Y
    Calcif Tissue Int; 2013 Sep; 93(3):276-87. PubMed ID: 23807531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of eldecalcitol, an active vitamin D analog, on hip structure and biomechanical properties: 3D assessment by clinical CT.
    Ito M; Nakamura T; Fukunaga M; Shiraki M; Matsumoto T
    Bone; 2011 Sep; 49(3):328-34. PubMed ID: 21605716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of reciprocal treatment with estrogen and estrogen plus parathyroid hormone on bone structure and strength in ovariectomized rats.
    Shen V; Birchman R; Xu R; Otter M; Wu D; Lindsay R; Dempster DW
    J Clin Invest; 1995 Nov; 96(5):2331-8. PubMed ID: 7593620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eldecalcitol Induces Minimodeling-Based Bone Formation and Inhibits Sclerostin Synthesis Preferentially in the Epiphyses Rather than the Metaphyses of the Long Bones in Rats.
    Hasegawa T; Yamamoto T; Hongo H; Yamamoto T; Haraguchi-Kitakamae M; Ishizu H; Shimizu T; Saito H; Sakai S; Yogo K; Matsumoto Y; Amizuka N
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of the effects of two anabolic agents (fluoride and PTH) on ash density and bone strength assessed in an osteopenic rat model.
    Søgaard CH; Mosekilde L; Thomsen JS; Richards A; McOsker JE
    Bone; 1997 May; 20(5):439-49. PubMed ID: 9145241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of treatment with parathyroid hormone 1-84 on quantity and biomechanical properties of thoracic vertebral trabecular bone in ovariectomized rhesus monkeys.
    Fox J; Newman MK; Turner CH; Guldberg RE; Varela A; Smith SY
    Calcif Tissue Int; 2008 Mar; 82(3):212-20. PubMed ID: 18297227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improvement of trochanteric bone quality in an osteoporosis model after short-term treatment with parathyroid hormone: a new mechanical test for trochanteric region of rat femur.
    Tezval M; Stuermer EK; Sehmisch S; Rack T; Stary A; Stebener M; Konietschke F; Stuermer KM
    Osteoporos Int; 2010 Feb; 21(2):251-61. PubMed ID: 19436940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No loss of biomechanical effects after withdrawal of short-term PTH treatment in an aged, osteopenic, ovariectomized rat model.
    Mosekilde L; Thomsen JS; McOsker JE
    Bone; 1997 May; 20(5):429-37. PubMed ID: 9145240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.